Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
McKinsey
UBS
Cantor Fitzgerald
Merck
Covington
Mallinckrodt
Colorcon
Medtronic

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,478,847

« Back to Dashboard

Summary for Patent: 5,478,847
Title: Methods of use for inhibiting bone loss and lowering serum cholesterol
Abstract:A method of inhibiting bone loss or resorption, or lowering serum cholesterol, comprising administering to a human in need thereof a compound having the formula ##STR1## or a pharmaceutically acceptable salt or solvate thereof, in a low dosage amount. Also encompased by the invention is a a pharmaceutical formulation in unit dosage form comprising, per unit dosage, a low dosage amount.
Inventor(s): Draper; Michael W. (Carmel, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/205,012
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,478,847

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,478,847

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway 950774 ➤ Sign Up
European Patent Office 0674903 ➤ Sign Up
Hungary 9500634 ➤ Sign Up
Hungary T72638 ➤ Sign Up
Israel 112593 ➤ Sign Up
Japan H07267861 ➤ Sign Up
Japan 2818384 ➤ Sign Up
Japan H10291932 ➤ Sign Up
Japan H10310525 ➤ Sign Up
Malaysia 130157 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Citi
US Department of Justice
Deloitte
UBS
Johnson and Johnson
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot